Abstract
The Human Epithelial Cell Cytotoxicity (HECC) Assay (Meth Cell Sci, 22: 17–24, 2000) has been modified to include three additional cell lines and to allow protocol adjustments for slow growing cell lines. This manuscript presents methods using human epithelial cells from ten different normal human tissues including: skin, mammary, prostate, renal, bronchial, lung, oral, ecto-cervix, colon, and liver. The HECC Assay can also be used to evaluate other types of drugs, personal care products, environmental chemicals, and potential toxicants. Human epithelial cells at an early passage are seeded into multi-well dishes. The cells are exposed to multiple concentrations of each test agent. A preliminary assay using an exposure of five days at 1 mM (if soluble) and four log dilutions is used to determine the highest concentration for the HECC Assay. In the HECC Assay, cultures are exposed for three to four days. Following the exposure period, endpoint measurements for inhibition of growth, mitochondrial function, and PCNA (proliferating cell nuclear antigen) expression or albumin synthesis (hepatocytes) are made. Data are analyzed to determine the concentration that inhibited an endpoint by 50 percent (TC50) for each agent in each target epithelial cell line or culture and the data are compared to determine the relative sensitivity of each epithelial cell line to the test agent.
Similar content being viewed by others
References
Elmore E, Luc T-T, Steele VE, Redpath JL (2001). Comparative tissue specific toxicities of 20 cancer preventive agents using cultured cells from eight different normal human epithelia. In Vitro Mol Toxicol 14: 191-207.
Elmore E, Luc T-T, Steele VE, Kelloff GJ, Redpath JL (2000). The human epithelial cell cytotoxicity assay for determining tissue specific toxicity. Meth Cell Sci 22: 17-24.
Steele VE, Wyatt GP, Elmore E (1998). Differential growth response to exogenous calcium in normal and carcinogen-exposed primary human keratinocyte cell cultures. Anticancer Res 18: 4067-4070.
Elmore E, Sun C, Li H-R, Wyatt GP, Buckmeier JA, Steele VE, Redpath JL (1997). The human epidermal cell assay for chemopreventive agents. Meth Cell Sci 19: 13-18.
Fields RD, Lancaster MV (1993). Dual-attribute continuous monitoring of cell proliferation/cytotoxicity. Am Biotech Lab 11: 48-50.
Tan CK, Castillo C, So AG, Downey KM (1986). An auxiliary protein for DNA polymerase delta from fetal calf thymus. J Biol Chem 261: 12310-12316.
Bravo R, Frank R, Blundell PA, MacDonald-Bravo H (1987). Cyclin/PCNA is the auxiliary protein of DNA polymerase delta. Nature 326: 515-517.
Prelich G, Tan CK, Kostura M, Mathews MB, So AG, Downey KM, Stillman B (1986). Functional identity of proliferating cell nuclear antigen and a DNA polymerase delta auxiliary protein. Nature 326: 517-520.
Johnson SE, Allen RE (1993). Proliferating cell nuclear antigen (PCNA) is expressed in activated rat skeletal muscle satellite cells. J Cell Physiol 154: 39-43.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Elmore, E., Siddiqui, S., Desai, N. et al. The human epithelial cell cytotoxicity assay for determining tissue specific toxicity: method modifications. Methods Cell Sci 24, 145–153 (2002). https://doi.org/10.1023/A:1024453300493
Issue Date:
DOI: https://doi.org/10.1023/A:1024453300493